RHEUMATIC DISEASE CLINICS OF NORTH AMERICA www.rheumatic.theclinics.com Consulting Editor MICHAEL H. WEISMAN February 2017 • Volume 43 • Number 1 Only gold members can continue reading. Log In or Register to continue Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related Related posts: Infection and Malignancy in Rheumatic Diseases Infection and Malignancy in Rheumatic Diseases Vaccines and Disease-Modifying Antirheumatic Drugs Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology Malignancy and Janus Kinase Inhibition The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era Tags: Rheumatic Disease Clinics of North America Volume 43 Issue 1 Sep 28, 2017 | Posted by drzezo in RHEUMATOLOGY | Comments Off on Infection and Malignancy in Rheumatic Diseases
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA www.rheumatic.theclinics.com Consulting Editor MICHAEL H. WEISMAN February 2017 • Volume 43 • Number 1 Only gold members can continue reading. Log In or Register to continue Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related Related posts: Infection and Malignancy in Rheumatic Diseases Infection and Malignancy in Rheumatic Diseases Vaccines and Disease-Modifying Antirheumatic Drugs Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology Malignancy and Janus Kinase Inhibition The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era Tags: Rheumatic Disease Clinics of North America Volume 43 Issue 1 Sep 28, 2017 | Posted by drzezo in RHEUMATOLOGY | Comments Off on Infection and Malignancy in Rheumatic Diseases